NDC Implements Voluntary Recall of the Hydrofinity™ Hydrophilic Guidewire

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

NDC Implements Voluntary Recall of the Hydrofinity™ Hydrophilic Guidewire

06/18/2014 03:01 PM EDT

Nitinol Devices & Components, Inc. (NDC) announced today a voluntary recall of its HydroFinity™ Hydrophilic Guidewires. The HydroFinity Guidewire is a product developed and manufactured by NDC and distributed by Covidien.

. For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? Please visit subscriberhelp.govdelivery.com
• Other inquiries? webmail@oc.fda.gov

---

This email was sent to filter@clubhouseb.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420

U.S. Department of Defense Defense News Lead Photo Update

You are subscribed to Defense News Lead Photo for U.S. Department of Defense. This information has recently been updated, and is now available. WINNEFELD REMARKS 06/18/2014 02:43 PM CDT Navy Adm. James A. Winnefeld Jr., vice chairman of the Joint Chiefs of Staff, addresses attendees during the Colorado Capitol Conference in Washington, D.C., Jun. 18, 2014. The conference provided an opportunity for Coloradans to meet and engage with national and key leaders.   Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your User Profile Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit subscriberhelp.govdelivery.com. Have another inquiry? Visit the online FAQ for up-to-date information. This service is provided to you at no charge by U.S. Department of Defense. Visit us on the web at http://www.defense.gov/. Updates from the U.S. Department of Defense

U.S. Department of Defense Defense News Lead Photo Update

You are subscribed to Defense News Lead Photo for U.S. Department of Defense. This information has recently been updated, and is now available. HAGEL ARRIVAL 06/18/2014 01:33 PM CDT Defense Secretary Chuck Hagel talks with U.S. Senator Susan Collins shortly before testifying before the Senate Appropriations Committee's defense subcommittee in Washington D.C., June 18, 2014, on the Defense Department's fiscal year 2015 budget request. Army Gen. Martin E. Dempsey, chairman of the Joint Chiefs of Staff, and Robert Hale, Defense Department comptroller, who arrived with Hagel, also testified.   Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your User Profile Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit subscriberhelp.govdelivery.com. Have another inquiry? Visit the online FAQ for up-to-date information. This service is provided to you at no charge by U.S. Department of Defense. Visit us on the web at http://www.defense.gov/. Updates from the U.S. Department of Defense

U.S. Department of Defense Defense News Lead Photo Update

You are subscribed to Defense News Lead Photo for U.S. Department of Defense. This information has recently been updated, and is now available. PATROL PLAN 06/18/2014 12:49 PM CDT U.S. Army 1st Lts. Matthew White, left, and Kenneth Hurst, center, hold a map while talking with U.S. Army Capt. Rodney Freeman, right, about the plan of movement for a patrol through Petawa village in Afghanistan's Parwan province, June 13, 2014. White, Hurst and Freeman are assigned to the 101st Airborne Division's Company A, 1st Battalion, 2nd Brigade Combat Team, Task Force Strike. The soldiers patrolled to disrupt enemy activity during the Afghan elections.   Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your User Profile Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit subscriberhelp.govdelivery.com. Have another inquiry? Visit the online FAQ for up-to-date information. This service is provided to you at no charge by U.S. Department of Defense. Visit us on the web at http://www.defense.gov/. Updates from the U.S. Department of Defense

Hospira Announces Voluntary Nationwide Recall of One Lot of 0.5% Marcaine™ (Bupivacaine HCI Injection, USP), 30 ML, Single-Dose, Preservative-Free Vial Due to Visible Particulates

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

Hospira Announces Voluntary Nationwide Recall of One Lot of 0.5% Marcaine™ (Bupivacaine HCI Injection, USP), 30 ML, Single-Dose, Preservative-Free Vial Due to Visible Particulates

06/17/2014 05:38 PM EDT

Hospira, Inc. (NYSE: HSP), announced today it will initiate a voluntary nationwide recall to the user level for one lot of 0.5% Marcaine™ (Bupivacaine HCl Injection, USP), 30 mL, Single-dose Vial – Preservative Free (NDC 0409-1560-29), Lot 33-545-DD. The recall is due to a confirmed customer report of particulate embedded in the glass vial as well as visible particulate in the solution.

. For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? Please visit subscriberhelp.govdelivery.com
• Other inquiries? webmail@oc.fda.gov

---

This email was sent to filter@clubhouseb.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420

Domega NY International Co Ltd Issues Allergy Alert On Undeclared Peanuts And Milk In Gong Xifacai Gift Chocolates

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

Domega NY International Co Ltd Issues Allergy Alert On Undeclared Peanuts And Milk In Gong Xifacai Gift Chocolates

06/17/2014 03:59 PM EDT

DOMEGA NY INTERNATIONAL CO LTD, 47-57 BRIDGEWATER STREET BROOKLYN NY 11222 is recalling Gong xiFacai gift chocolates because it contains undeclared peanuts and milk. Consumers who have allergies to peanuts and milk run the risk of serious or life-threatening allergic reactions if they consume this product.

. For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? Please visit subscriberhelp.govdelivery.com
• Other inquiries? webmail@oc.fda.gov

---

This email was sent to filter@clubhouseb.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420

Vita Food Products Issues Voluntary Recall of 4oz Vita Classic Premium Sliced Smoked Atlantic Salmon Due to Possible Health Risk

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

Vita Food Products Issues Voluntary Recall of 4oz Vita Classic Premium Sliced Smoked Atlantic Salmon Due to Possible Health Risk

06/17/2014 07:34 PM EDT

Chicago, Illinois – June 16, 2014 – Vita Food Products, Inc. of Chicago, Illinois is notifying the public that it is recalling 1,878 pounds of Vita Classic Premium Sliced Smoked Atlantic Salmon due to possible contamination of Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea.

. For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? Please visit subscriberhelp.govdelivery.com
• Other inquiries? webmail@oc.fda.gov

---

This email was sent to filter@clubhouseb.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420